Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide (Q40269885)

19 September 2017

title

Activation of the mitogen- and stress-activated kinase 1 by arsenic trioxide (English)

1 reference

19 September 2017

3

Martin S Tallman

1 reference

19 September 2017

author name string

Padma Kannan-Thulasiraman

1

1 reference

19 September 2017

Efstratios Katsoulidis

2

1 reference

19 September 2017

J Simon C Arthur

4

1 reference

19 September 2017

Leonidas C Platanias

5

1 reference

19 September 2017

language of work or name

English

0 references

publication date

8 June 2006

1 reference

Journal of Biological Chemistry

19 September 2017

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

32

1 reference

19 September 2017

page(s)

22446-22452

1 reference

Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Expanding the use of arsenic trioxide: leukemias and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Acute promyelocytic leukemia: evolving therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Arsenic trioxide: its role in acute promyelocytic leukemia and potential in other hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

The potential of arsenic trioxide in the treatment of malignant disease: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Opportunities for Trisenox (arsenic trioxide) in the treatment of myelodysplastic syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Signal transduction by the JNK group of MAP kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Mitogen-activated protein kinases: specific messages from ubiquitous messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Map kinase signaling pathways and hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MAP kinases in the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Signal transduction by MAP kinases in T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Interferon-α Engages the Insulin Receptor Substrate-1 to Associate with the Phosphatidylinositol 3′-Kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

The type I interferon receptor mediates tyrosine phosphorylation of the CrkL adaptor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Activation of the p38 mitogen-activated protein kinase mediates the suppressive effects of type I interferons and transforming growth factor-beta on normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Activation of the p38 mitogen-activated protein kinase by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Role of p38alpha Map kinase in Type I interferon signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

ERKs and p38 kinases mediate ultraviolet B-induced phosphorylation of histone H3 at serine 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Involvement of ERKs and mitogen- and stress-activated protein kinase in UVC-induced phosphorylation of ATF2 in JB6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MSK1 activity is controlled by multiple phosphorylation sites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

The nucleosomal response associated with immediate-early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG-14 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Role of the p38 mitogen-activated protein kinase pathway in cytokine-mediated hematopoietic suppression in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

JNK activation is a mediator of arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Arsenic trioxide inhibits nuclear receptor function via SEK1/JNK-mediated RXRalpha phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Ascorbic acid enhances arsenic trioxide-induced cytotoxicity in multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Pharmacologic inhibitors of PI3K/Akt potentiate the apoptotic action of the antileukemic drug arsenic trioxide via glutathione depletion and increased peroxide accumulation in myeloid leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

The Ras-MAPK signal transduction pathway, cancer and chromatin remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MAPK-regulated transcription: a continuously variable gene switch?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Increased Ser-10 phosphorylation of histone H3 in mitogen-stimulated and oncogene-transformed mouse fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Mitogen- and stress-activated protein kinase 1 mediates cAMP response element-binding protein phosphorylation and activation by neurotrophins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

The kinases MSK1 and MSK2 are required for epidermal growth factor-induced, but not tumor necrosis factor-induced, histone H3 Ser10 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

Nuclear hormone receptor NR4A2 is involved in cell transformation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M603111200

21 January 2018

Identifiers

DOI

10.1074/JBC.M603111200

1 reference

19 September 2017

1 reference